Basic Materials / Specialty ChemicalsBSE
$73.00
+0.01 (+0.01%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 18%
FCF escenarios
weak_data · normalized FCF $-29.4M · quality 43.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
31/100
D
Piotroski
4/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$368M
P/E
20.1x
↑EV/EBITDA
11.7x
↑ROE
-30.1%
↓Gross Margin
99.6%
↑Debt/Equity
-4.69
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2023–2026 · 3 años de histórico normalizado
Revenue CAGR
-21.3%
FCF CAGR
—
FCF margin
-24.9%
FCF / Net income
-3.11x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $229.6M · net income $18.4M · FCF $-57.1M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $229.6M | $229.6M | $405.8M | $452.6M | $471.1M |
| Net Income | $18.4M | $18.4M | $-70.0M | $-32.3M | $-7.9M |
| EBITDA | $55.6M | $55.6M | $-21.9M | $16.5M | $40.0M |
| EPS | 3.64 | 3.64 | -13.90 | -6.60 | -1.65 |
| Gross Margin | 99.6% | 99.6% | 99.9% | 97.0% | 96.0% |
| Operating Margin | -24.5% | -24.5% | -14.0% | -4.6% | 0.9% |
| Net Margin | 8.0% | 8.0% | -17.3% | -7.1% | -1.7% |
| Balance Sheet | |||||
| Debt/Equity | -4.69 | -4.69 | -2.72 | -19.76 | -18.31 |
| Current Ratio | 0.44 | 0.44 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-57.1M | $-57.1M | $-3.7M | $-29.4M | $13.7M |
| Returns | |||||
| ROE | -30.1% | -30.1% | 87.4% | 323.4% | 84.9% |
| Valuation | |||||
| P/E | 20.05 | 20.05 | — | — | — |
| EV/EBITDA | 11.67 | 11.67 | — | 49.29 | 14.62 |
| Growth & Yield | |||||
| Revenue Growth | -43.4% | -43.4% | -10.3% | -3.9% | — |
| EPS Growth | 126.2% | 126.2% | -110.6% | -300.0% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
21.2%
EPS terminal req.
$6.48
Spread vs growth
105.0%
5Y implied EPS CAGR
16.6%
EPS terminal req.
$7.84
Spread vs growth
109.6%
10Y implied EPS CAGR
13.2%
EPS terminal req.
$12.62
Spread vs growth
112.9%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-34.1%
Start / end P/E
n/dx → n/dx
EPS bridge
-13.90 → 3.64
Residual
-34.1%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.